BSE filing, NSE: SYMBIOTEC. Summary written from the filing by ALFA Finder's alert engine.
Symbiotec Pharmalab Ltd: key numbers
- Share price
- ₹1,274.70
- Market cap
- ₹8,191 Cr
- Revenue (annual)
- ₹869.1 Cr
- Net profit (annual)
- ₹109.9 Cr
- Promoter holding
- 33.28%
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Symbiotec Pharmalab Ltd
All →Symbiotec Pharmalab Board Meeting Date
Symbiotec Pharmalab schedules a 5 November 2026 board meeting to consider unaudited quarterly and half-year results. No amounts are proposed.
Symbiotec Pharmalab Other Announcement
Symbiotec Pharmalab Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31 of the SEBI LODR Regulations.
Symbiotec Pharmalab Other Announcement
Symbiotec Pharmalab has filed the routine quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ending September 30, 2026.
Symbiotec Pharmalab Other Announcement
Designated persons of Symbiotec Pharmalab sold equity shares worth ₹11.94 crore in the open market. This disclosure complies with PIT Regulation 7(2).
- Value
- ₹11.94 Cr
Symbiotec Pharmalab Business Update
Symbiotec Pharmalab received an Establishment Inspection Report (EIR) from the U.S. FDA for its Pithampur manufacturing facility. The inspection concluded with a Voluntary Action Indicated (VAI) classification.
- From
- U.S. Food and Drug Administration (U.S. FDA)
Symbiotec Pharmalab Earnings Call Transcript: Key Takeaways
Symbiotec reported Q1 FY27 Revenue of ₹218 Cr, but underlying PAT remains soft due to heavy pre-operative expense drags from unmonetized new business segments.
- Call
- Guides 20% growth
Other share pledge announcements
All →TVS Holdings Share Pledge
Promoter trusts pledged TVS Holdings shares to JM Financial entities as security for credit facilities. The pledge covers 16,75,800 shares, or 8.28% of total share capital.
Paisalo Digital Share Pledge
Equilibrated Venture Cflow, a promoter group entity, pledged 2.98 crore Paisalo shares on October 26, 2026. The pledge secures a Rs.25 Crore third-party loan from Jio Credit.
- Value
- ₹25.00 Cr
Paisalo Digital Share Pledge
Promoter group entity Equilibrated Venture Cflow pledged 1,03,63,523 shares, valued at Rs.79.59 Crore, on October 26, 2026. Promoter holding stays at 20.64% after the pledge.
- Value
- ₹79.59 Cr
Billionbrains Garage Ventures Share Pledge
Golden Oak Trust (promoter group) pledged 1,50,000 shares of Billionbrains Garage Ventures to Aditya Birla Capital Ltd. The pledge covers 0.24% of total share capital, dated 19-Oct-2026.
Medplus Health Services Share Pledge
Catalyst Trusteeship pledged 34,00,000 Medplus Health Services shares (2.83%) as debenture collateral. Total encumbered shares rose to 2,41,50,400 (20.10% of capital).
Royal Sense Share Pledge
Royal Sense promoter Rishabh Arora released a pledge on 10,00,000 shares on September 17, 2026. A supporting letter corrects the post-event encumbered holding to nil.